Vivus Calls First Manhattan’s Board Change A Serious Threat – ValueWalk Premium
Vivus

Vivus Calls First Manhattan’s Board Change A Serious Threat

VIVUS, Inc. (NASDAQ:VVUS) today sent a letter to its shareholders indicating First Manhattan Co’s campaign to replace Vivus’ existing board a serious threat.

The pharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity and sexual health in its today’s letter to the shareholders, emphasized that there is

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk
0